The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Precision Medicine-Global Market Insights and Sales Trends 2025

Precision Medicine-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1823887

No of Pages : 114

Ask Your Query

Synopsis

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

The global Precision Medicine market size is expected to reach US$ 227820 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Precision Medicine in various end use industries. The expanding demands from the Oncology, Neurosciences, Immunology and Respiratory, are propelling Precision Medicine market. Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapies segment is estimated at % CAGR for the next seven-year period.

The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.

Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.

Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Precision Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Precision Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Precision Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Precision Medicine sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Precision Medicine covered in this report include Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation and Biomrieux Sa, etc.

The global Precision Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Johnson & Johnson
  • Roche
  • Labcorp
  • Abbott Laboratories
  • Novartis
  • Illumina
  • GE Healthcare
  • Intel Corporation
  • Biomrieux Sa
  • Cepheid
  • IBM
  • Qiagen
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Almac Group
  • Healthcore

Global Precision Medicine market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Precision Medicine market, Segment by Type:

  • Diagnostics
  • Therapies

Global Precision Medicine market, by Application

  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Precision Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Precision Medicine
1.1 Precision Medicine Market Overview
1.1.1 Precision Medicine Product Scope
1.1.2 Precision Medicine Market Status and Outlook
1.2 Global Precision Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Precision Medicine Market Size by Region (2018-2029)
1.4 Global Precision Medicine Historic Market Size by Region (2018-2023)
1.5 Global Precision Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Precision Medicine Market Size (2018-2029)
1.6.1 North America Precision Medicine Market Size (2018-2029)
1.6.2 Europe Precision Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Precision Medicine Market Size (2018-2029)
1.6.4 Latin America Precision Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Precision Medicine Market Size (2018-2029)
2 Precision Medicine Market by Type
2.1 Introduction
2.1.1 Diagnostics
2.1.2 Therapies
2.2 Global Precision Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Precision Medicine Historic Market Size by Type (2018-2023)
2.2.2 Global Precision Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Precision Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Precision Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Precision Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Precision Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Precision Medicine Revenue Breakdown by Type (2018-2029)
3 Precision Medicine Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Neurosciences
3.1.3 Immunology
3.1.4 Respiratory
3.1.5 Others
3.2 Global Precision Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Precision Medicine Historic Market Size by Application (2018-2023)
3.2.2 Global Precision Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Precision Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Precision Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Precision Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Precision Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Precision Medicine Revenue Breakdown by Application (2018-2029)
4 Precision Medicine Competition Analysis by Players
4.1 Global Precision Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Precision Medicine as of 2022)
4.3 Date of Key Players Enter into Precision Medicine Market
4.4 Global Top Players Precision Medicine Headquarters and Area Served
4.5 Key Players Precision Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Precision Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Precision Medicine Products, Services and Solutions
5.1.4 Johnson & Johnson Precision Medicine Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Precision Medicine Products, Services and Solutions
5.2.4 Roche Precision Medicine Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Labcorp
5.3.1 Labcorp Profile
5.3.2 Labcorp Main Business
5.3.3 Labcorp Precision Medicine Products, Services and Solutions
5.3.4 Labcorp Precision Medicine Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Precision Medicine Products, Services and Solutions
5.4.4 Abbott Laboratories Precision Medicine Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Precision Medicine Products, Services and Solutions
5.5.4 Novartis Precision Medicine Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Illumina
5.6.1 Illumina Profile
5.6.2 Illumina Main Business
5.6.3 Illumina Precision Medicine Products, Services and Solutions
5.6.4 Illumina Precision Medicine Revenue (US$ Million) & (2018-2023)
5.6.5 Illumina Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Precision Medicine Products, Services and Solutions
5.7.4 GE Healthcare Precision Medicine Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 Intel Corporation
5.8.1 Intel Corporation Profile
5.8.2 Intel Corporation Main Business
5.8.3 Intel Corporation Precision Medicine Products, Services and Solutions
5.8.4 Intel Corporation Precision Medicine Revenue (US$ Million) & (2018-2023)
5.8.5 Intel Corporation Recent Developments
5.9 Biomrieux Sa
5.9.1 Biomrieux Sa Profile
5.9.2 Biomrieux Sa Main Business
5.9.3 Biomrieux Sa Precision Medicine Products, Services and Solutions
5.9.4 Biomrieux Sa Precision Medicine Revenue (US$ Million) & (2018-2023)
5.9.5 Biomrieux Sa Recent Developments
5.10 Cepheid
5.10.1 Cepheid Profile
5.10.2 Cepheid Main Business
5.10.3 Cepheid Precision Medicine Products, Services and Solutions
5.10.4 Cepheid Precision Medicine Revenue (US$ Million) & (2018-2023)
5.10.5 Cepheid Recent Developments
5.11 IBM
5.11.1 IBM Profile
5.11.2 IBM Main Business
5.11.3 IBM Precision Medicine Products, Services and Solutions
5.11.4 IBM Precision Medicine Revenue (US$ Million) & (2018-2023)
5.11.5 IBM Recent Developments
5.12 Qiagen
5.12.1 Qiagen Profile
5.12.2 Qiagen Main Business
5.12.3 Qiagen Precision Medicine Products, Services and Solutions
5.12.4 Qiagen Precision Medicine Revenue (US$ Million) & (2018-2023)
5.12.5 Qiagen Recent Developments
5.13 Thermo Fisher Scientific
5.13.1 Thermo Fisher Scientific Profile
5.13.2 Thermo Fisher Scientific Main Business
5.13.3 Thermo Fisher Scientific Precision Medicine Products, Services and Solutions
5.13.4 Thermo Fisher Scientific Precision Medicine Revenue (US$ Million) & (2018-2023)
5.13.5 Thermo Fisher Scientific Recent Developments
5.14 Randox Laboratories
5.14.1 Randox Laboratories Profile
5.14.2 Randox Laboratories Main Business
5.14.3 Randox Laboratories Precision Medicine Products, Services and Solutions
5.14.4 Randox Laboratories Precision Medicine Revenue (US$ Million) & (2018-2023)
5.14.5 Randox Laboratories Recent Developments
5.15 Almac Group
5.15.1 Almac Group Profile
5.15.2 Almac Group Main Business
5.15.3 Almac Group Precision Medicine Products, Services and Solutions
5.15.4 Almac Group Precision Medicine Revenue (US$ Million) & (2018-2023)
5.15.5 Almac Group Recent Developments
5.16 Healthcore
5.16.1 Healthcore Profile
5.16.2 Healthcore Main Business
5.16.3 Healthcore Precision Medicine Products, Services and Solutions
5.16.4 Healthcore Precision Medicine Revenue (US$ Million) & (2018-2023)
5.16.5 Healthcore Recent Developments
6 North America
6.1 North America Precision Medicine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Precision Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Precision Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Precision Medicine Market Dynamics
11.1 Precision Medicine Industry Trends
11.2 Precision Medicine Market Drivers
11.3 Precision Medicine Market Challenges
11.4 Precision Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock